| Literature DB >> 24178248 |
Dmitri E Iarikov1, John Alexander, Sumathi Nambiar.
Abstract
We report hypersensitivity reactions associated with fidaxomicin, an antibacterial drug approved for the treatment of Clostridium difficile-associated diarrhea. These reactions are viewed as significant because of severity and unexpected because fidaxomicin is minimally absorbed. The fidaxomicin labeling was revised to include information about the possibility of hypersensitivity reactions.Entities:
Keywords: adverse reactions; fidaxomicin; hypersensitivity
Mesh：
Substances：
Year: 2013 PMID： 24178248 DOI： 10.1093/cid/cit719
Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079